-
1
-
-
0032746068
-
Thrombophilia-associated pregnancy wastage
-
Blumenfeld Z, Brenner B. Thrombophilia-associated pregnancy wastage. Fertil Steril 1999; 72: 765-774.
-
(1999)
Fertil Steril
, vol.72
, pp. 765-774
-
-
Blumenfeld, Z.1
Brenner, B.2
-
3
-
-
38549100335
-
The haemostatic role of tissue factor pathway inhibitor
-
Crawley JT, Lane DA. The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2008; 28: 233-242.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 233-242
-
-
Crawley, J.T.1
Lane, D.A.2
-
4
-
-
47249084343
-
Advances in understanding pathogenic mechanisms of thrombophilic disorders
-
Dahlbäck B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 2008; 112: 19-27.
-
(2008)
Blood
, vol.112
, pp. 19-27
-
-
Dahlbäck, B.1
-
5
-
-
74249121899
-
Thrombin generation as an intermediate phenotype for venous thrombosis
-
Segers O, van Oerle R, ten Cate H, et al. Thrombin generation as an intermediate phenotype for venous thrombosis. Thromb Haemost 2010; 103: 114-122.
-
(2010)
Thromb Haemost
, vol.103
, pp. 114-122
-
-
Segers, O.1
van Oerle, R.2
Ten, C.H.3
-
6
-
-
84874769993
-
-
IBGE. Available at, Accessed May 9
-
IBGE. Available at: http://www.ibge.gov.br/home/estatistica/populacao/censo2010/.Accessed May 9, 2012.
-
(2012)
-
-
-
7
-
-
0031825212
-
Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil
-
Andrade FL, Annichino-Bizzacchi JM, Saad ST, et al. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol 1998; 59: 46-50.
-
(1998)
Am J Hematol
, vol.59
, pp. 46-50
-
-
Andrade, F.L.1
Annichino-Bizzacchi, J.M.2
Saad, S.T.3
-
8
-
-
0029850530
-
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
-
Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
-
(1996)
Blood
, vol.88
, pp. 3698-3703
-
-
Poort, S.R.1
Rosendaal, F.R.2
Reitsma, P.H.3
-
9
-
-
0036155283
-
Score tests for association between traits and haplotypes when linkage phase is ambiguous
-
Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
-
(2002)
Am J Hum Genet
, vol.70
, pp. 425-434
-
-
Schaid, D.J.1
Rowland, C.M.2
Tines, D.E.3
-
10
-
-
60849101359
-
Polymorphisms in the protein C gene as risk factor for venous thrombosis
-
Pomp ER, Doggen CJ, Vos HL, et al. Polymorphisms in the protein C gene as risk factor for venous thrombosis. Thromb Haemost 2009; 101: 62-67.
-
(2009)
Thromb Haemost
, vol.101
, pp. 62-67
-
-
Pomp, E.R.1
Doggen, C.J.2
Vos, H.L.3
-
11
-
-
23044457444
-
Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: A population-based case-control study
-
Heit JA, Petterson TM, Owen WG, et al. Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study. J Thromb Haemost 2005; 3: 710-717.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 710-717
-
-
Heit, J.A.1
Petterson, T.M.2
Owen, W.G.3
-
12
-
-
0036335480
-
The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations
-
Ameziane N, Seguin C, Borgel D, et al. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations. Thromb Haemost 2002; 88: 195-199.
-
(2002)
Thromb Haemost
, vol.88
, pp. 195-199
-
-
Ameziane, N.1
Seguin, C.2
Borgel, D.3
-
13
-
-
34548364003
-
Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden
-
Lincz LF, Adams MJ, Scorgie FE, et al. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden. Blood Coagul Fibrinolysis 2007; 18: 559-564.
-
(2007)
Blood Coagul Fibrinolysis
, vol.18
, pp. 559-564
-
-
Lincz, L.F.1
Adams, M.J.2
Scorgie, F.E.3
-
14
-
-
77951875025
-
Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
-
Opstad TB, Pettersen AA, Weiss T, et al. Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes. Thromb J 2010; 8: 7.
-
(2010)
Thromb J
, vol.8
, pp. 7
-
-
Opstad, T.B.1
Pettersen, A.A.2
Weiss, T.3
-
15
-
-
79959509071
-
Tissue factor and tissue factor pathway inhibitors TFPI and TFPI2 in human secretory endometrium--possible link to female infertility
-
Altmäe S, Salumets A, Bjuresten K, et al. Tissue factor and tissue factor pathway inhibitors TFPI and TFPI2 in human secretory endometrium--possible link to female infertility. Reprod Sci 2011; 18: 666-678.
-
(2011)
Reprod Sci
, vol.18
, pp. 666-678
-
-
Altmäe, S.1
Salumets, A.2
Bjuresten, K.3
-
16
-
-
0032892214
-
Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects - Impact of the V264M substitution on plasma levels of TFPI
-
Moatti D, Seknadji P, Galand C, et al. Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects - Impact of the V264M substitution on plasma levels of TFPI. Arterioscler Thromb Vasc Biol 1999; 19: 862-869.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 862-869
-
-
Moatti, D.1
Seknadji, P.2
Galand, C.3
-
17
-
-
0033854157
-
A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels
-
Moatti D, Haidar B, Fumeron F, et al. A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels. Thromb Haemost 2000; 84: 244-249.
-
(2000)
Thromb Haemost
, vol.84
, pp. 244-249
-
-
Moatti, D.1
Haidar, B.2
Fumeron, F.3
-
18
-
-
77955920295
-
Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy
-
Opstad TB, Eilertsen AL, Høibraaten E, et al. Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy. Blood Coagul Fibrinolysis 2010; 21: 516-521.
-
(2010)
Blood Coagul Fibrinolysis
, vol.21
, pp. 516-521
-
-
Opstad, T.B.1
Eilertsen, A.L.2
Høibraaten, E.3
-
19
-
-
40949145685
-
Gene variants associated with deep vein thrombosis
-
Bezemer ID, Bare LA, Doggen CJ, et al. Gene variants associated with deep vein thrombosis. J Am Med Assoc 2008; 299: 1306-1314.
-
(2008)
J Am Med Assoc
, vol.299
, pp. 1306-1314
-
-
Bezemer, I.D.1
Bare, L.A.2
Doggen, C.J.3
-
20
-
-
11444253333
-
Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis
-
Gadelha T, André C, Jucá AA, et al. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis 2005; 19: 49-52.
-
(2005)
Cerebrovasc Dis
, vol.19
, pp. 49-52
-
-
Gadelha, T.1
André, C.2
Jucá, A.A.3
-
21
-
-
33751092579
-
A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study)
-
Pereira AC, Lourenço DM, Maffei FH, et al. A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study). Thromb Res 2007; 119: 183-188.
-
(2007)
Thromb Res
, vol.119
, pp. 183-188
-
-
Pereira, A.C.1
Lourenço, D.M.2
Maffei, F.H.3
-
24
-
-
79951895658
-
The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected
-
Pena SD, Di Pietro G, Fuchshuber-Moraes M, et al. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 2011; 6: e17063.
-
(2011)
PLoS One
, vol.6
-
-
Pena, S.D.1
Di Pietro, G.2
Fuchshuber-Moraes, M.3
-
25
-
-
83255185151
-
Brazilian urban population genetic structure reveals a high degree of admixture
-
Giolo SR, Soler JM, Greenway SC, et al. Brazilian urban population genetic structure reveals a high degree of admixture. Eur J Hum Genet 2012; 20: 111-116.
-
(2012)
Eur J Hum Genet
, vol.20
, pp. 111-116
-
-
Giolo, S.R.1
Soler, J.M.2
Greenway, S.C.3
-
27
-
-
66349128292
-
Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels
-
Antón AI, Teruel R, Corral J, et al. Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels. Haematologica 2009; 94: 589-592.
-
(2009)
Haematologica
, vol.94
, pp. 589-592
-
-
Antón, A.I.1
Teruel, R.2
Corral, J.3
-
28
-
-
0038481254
-
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
-
Dahm A, Van Hylckama Vlieg A, Bendz B, et al. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood 2003; 101: 4387-4392.
-
(2003)
Blood
, vol.101
, pp. 4387-4392
-
-
Dahm, A.1
van Hylckama, V.A.2
Bendz, B.3
-
29
-
-
0035014293
-
Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis
-
Amini-Nekoo A, Futers TS, Moia M, et al. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br J Haematol 2001; 113: 537-543.
-
(2001)
Br J Haematol
, vol.113
, pp. 537-543
-
-
Amini-Nekoo, A.1
Futers, T.S.2
Moia, M.3
-
30
-
-
41749089852
-
Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter
-
Amini Nekoo A, Iles D. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter. Thromb Res 2008; 121: 813-819.
-
(2008)
Thromb Res
, vol.121
, pp. 813-819
-
-
Amini, N.A.1
Iles, D.2
-
31
-
-
77955450362
-
Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology
-
Zakai NA, Lutsey PL, Folsom AR, et al. Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology. Thromb Haemost 2010; 104: 207-212.
-
(2010)
Thromb Haemost
, vol.104
, pp. 207-212
-
-
Zakai, N.A.1
Lutsey, P.L.2
Folsom, A.R.3
-
32
-
-
27144521697
-
Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism
-
Hoke M, Kyrle PA, Minar E, et al. Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism. Thromb Haemost 2005; 94: 787-790.
-
(2005)
Thromb Haemost
, vol.94
, pp. 787-790
-
-
Hoke, M.1
Kyrle, P.A.2
Minar, E.3
-
33
-
-
0030738021
-
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice
-
Huang ZF, Higuchi D, Lasky N, et al. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 1997; 90: 944-951.
-
(1997)
Blood
, vol.90
, pp. 944-951
-
-
Huang, Z.F.1
Higuchi, D.2
Lasky, N.3
-
34
-
-
0031877879
-
C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis
-
Miyata T, Sakata T, Kumeda K, et al. C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis. Thromb Haemost 1998; 80: 345-346.
-
(1998)
Thromb Haemost
, vol.80
, pp. 345-346
-
-
Miyata, T.1
Sakata, T.2
Kumeda, K.3
-
35
-
-
77953616244
-
Functional characterization of polymorphisms in the human TFPI gene
-
Skretting G, Stavik B, Landvik NE, et al. Functional characterization of polymorphisms in the human TFPI gene. Biochem Biophys Res Commun 2010; 397: 106-111.
-
(2010)
Biochem Biophys Res Commun
, vol.397
, pp. 106-111
-
-
Skretting, G.1
Stavik, B.2
Landvik, N.E.3
-
36
-
-
0024431644
-
Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy
-
Sandset PM, Hellgren M, Uvebrandt M, et al. Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy. Thromb Res 1989; 55: 665-670.
-
(1989)
Thromb Res
, vol.55
, pp. 665-670
-
-
Sandset, P.M.1
Hellgren, M.2
Uvebrandt, M.3
-
37
-
-
38949156864
-
Calibrated automated thrombin generation in normal uncomplicated pregnancy
-
Rosenkranz A, Hiden M, Leschnik B, et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 2008; 99: 331-337.
-
(2008)
Thromb Haemost
, vol.99
, pp. 331-337
-
-
Rosenkranz, A.1
Hiden, M.2
Leschnik, B.3
-
38
-
-
78651090749
-
Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy
-
Ittel A, Bretelle F, Gris JC, et al. Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy. Thromb Haemost 2011; 105: 66-71.
-
(2011)
Thromb Haemost
, vol.105
, pp. 66-71
-
-
Ittel, A.1
Bretelle, F.2
Gris, J.C.3
-
39
-
-
0030787451
-
Changes in activated protein C resistance during normal pregnancy
-
Walker MC, Garner PR, Keely EJ, et al. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997; 177: 162-169.
-
(1997)
Am J Obstet Gynecol
, vol.177
, pp. 162-169
-
-
Walker, M.C.1
Garner, P.R.2
Keely, E.J.3
-
40
-
-
33644772164
-
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor
-
Hackeng TM, Seré KM, Tans G, et al. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci USA 2006; 103: 3106-3111.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 3106-3111
-
-
Hackeng, T.M.1
Seré, K.M.2
Tans, G.3
-
41
-
-
25144517256
-
Determinants of the APTTand ETP-based APC sensitivity tests
-
de Visser MC, van Hylckama Vlieg A, Tans G, et al. Determinants of the APTTand ETP-based APC sensitivity tests. J Thromb Haemost 2005; 3: 1488-1494.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1488-1494
-
-
de Visser, M.C.1
van Hylckama, V.A.2
Tans, G.3
-
42
-
-
0020079791
-
Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C
-
Nesheim ME, Canfield WM, Kisiel W, et al. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. J Biol Chem 1982; 257: 1443-1447.
-
(1982)
J Biol Chem
, vol.257
, pp. 1443-1447
-
-
Nesheim, M.E.1
Canfield, W.M.2
Kisiel, W.3
-
43
-
-
0028810678
-
Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C
-
Rosing J, Hoekema L, Nicolaes GA, et al. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 27852-27858.
-
(1995)
J Biol Chem
, vol.270
, pp. 27852-27858
-
-
Rosing, J.1
Hoekema, L.2
Nicolaes, G.A.3
-
44
-
-
0033557951
-
A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis
-
de Visser MC, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 1999; 93: 1271-1276.
-
(1999)
Blood
, vol.93
, pp. 1271-1276
-
-
de Visser, M.C.1
Rosendaal, F.R.2
Bertina, R.M.3
-
45
-
-
0033586755
-
Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism
-
Rodeghiero F, Tosetto A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1999; 130: 643-650.
-
(1999)
Ann Intern Med
, vol.130
, pp. 643-650
-
-
Rodeghiero, F.1
Tosetto, A.2
-
46
-
-
33750976714
-
Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C
-
Gardiner C, Cohen H, Austin SK, et al. Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. J Thromb Haemost 2006; 4: 2724-2726.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 2724-2726
-
-
Gardiner, C.1
Cohen, H.2
Austin, S.K.3
-
47
-
-
28444450102
-
Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment
-
Aharon A, Lanir N, Drugan A, et al. Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment. J Thromb Haemost 2005; 3: 2355-2357.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2355-2357
-
-
Aharon, A.1
Lanir, N.2
Drugan, A.3
|